These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells. Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323 [TBL] [Abstract][Full Text] [Related]
4. Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1). Gururaj AE; Peng S; Vadlamudi RK; Kumar R Mol Endocrinol; 2007 Aug; 21(8):1847-60. PubMed ID: 17505058 [TBL] [Abstract][Full Text] [Related]
5. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein. Balasenthil S; Vadlamudi RK J Biol Chem; 2003 Jun; 278(24):22119-27. PubMed ID: 12682072 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor. Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633 [TBL] [Abstract][Full Text] [Related]
7. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells. Nair SS; Mishra SK; Yang Z; Balasenthil S; Kumar R; Vadlamudi RK Cancer Res; 2004 Sep; 64(18):6416-23. PubMed ID: 15374949 [TBL] [Abstract][Full Text] [Related]
8. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation. Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929 [TBL] [Abstract][Full Text] [Related]
11. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Popov VM; Zhou J; Shirley LA; Quong J; Yeow WS; Wright JA; Wu K; Rui H; Vadlamudi RK; Jiang J; Kumar R; Wang C; Pestell RG Cancer Res; 2009 Jul; 69(14):5752-60. PubMed ID: 19605405 [TBL] [Abstract][Full Text] [Related]
12. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2. Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406 [TBL] [Abstract][Full Text] [Related]
13. Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells. Pan Y; Wang X; Zhang Y; Qiao J; Sasano H; McNamara K; Zhao B; Zhang D; Fan Y; Liu L; Jia X; Liu M; Song S; Wang L Horm Cancer; 2020 Apr; 11(2):87-96. PubMed ID: 32037484 [TBL] [Abstract][Full Text] [Related]